News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
|
Followers
|
308
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
32544
|
|
Created
|
02/28/08
|
Type
|
Free
|
| Moderators | |||
Delray Beach, FL-based PositiveID has received FDA clearance for its iglucose mobile health system for diabetes management. The system uses mobile technology to help diabetics manage their condition by communicating glucose readings from data-capable glucometers to the iglucose management portal.
Johnson & Johnson Nipro ???
The iglucose system collects and transmits stored data from a variety of blood glucose meters, including Johnson & Johnson's ($JNJ) LifeScan OneTouch and Nipro Diagnostic True monitoring systems, to a secure database by wireless cellular technology.
Over the coming months, the company plans initial roll-outs with several partners. PositiveID already has the wireless infrastructure in place through partnerships with AT&T in the U.S. and Rogers Communications in Canada, and will look to add additional wireless partners.
"iglucose is a safe, flexible, convenient, cost-effective and straightforward solution that we believe will revolutionize the way people with diabetes manage their condition," explains company CEO William Caragol in a statement. "iglucose represents an opportunity to help decrease costs to our healthcare system by helping to improve disease management and patient compliance. This FDA clearance is an important validation of our product offering for PositiveID and we will work diligently to make iglucose available to everyone affected by diabetes in the near future."
PositiveID is focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. It was formed in November 2009 through the merger of VeriChip Corporation and Steel Vault Corporation, according to the company's website.
The company has worked with a number of big names in the pharma and medical devices industries. Early last month, it announced that its iglucose will be used in a diabetes study sponsored by the American Medical Directors Association Foundation and supported by Sanofi ($SNY).
https://www.sec.gov/Archives/edgar/data/1347022/000000000015057349/filename1.pdf
3. Please revise to clarify the reasons for the increase to your authorized shares, in light of the increases you obtained in November 2014 and April 2015. We note, for example, that your disclosures here regarding the reasons for the increase are substantially similar to the reasons for the increases disclosed in November 2014 and April 2015; however, it is unclear from your current disclosure why the prior increases were insufficient.
On December 20th, 2012, PositiveID Corporation (PSID) announced they have teamed up with The Boeing Company for a licensing agreement that could lead to big profits for both companies. The Boeing Company will manufacture and sell PositiveID’s M-BAND bio-threat detection devices in North America, while PositiveID secures reoccurring revenue streams by retaining the rights to sell the reagents and assays for the devices.
What is Bio Watch 3?
Bio Watch Generation 3, a program being procured by Homeland security and estimated to cost $3 billion, involves the deployment and testing of an estimated 2,500 M-BAND units as part of the Department of Homeland Security’s Bio Watch Generation 3 program, set to roll out over the next five to six years...
...In addition to bio-threat detection technology, PositiveID’s HealthID division is focused on providing health solutions for consumers, businesses and animals, such as blood glucose monitoring, rapid virus detection, and various other products aiding diabetes management. Products announced so far include iglucose, Easy Check and GlucoChip.
1 year chart flatlines, more than that wiped out terrible...
ALL THE PRODUCTS FAIL ..... SO CAN MAKE MORE MONEY .....
REPEATED REVERSE SPLIT PENNY-SCAM
BUYER BEWARE
